Regulations.gov document
Drugs for Human Use; Drug Efficacy Study Implementation; Oral Prescription Drugs…
Notice · FDA-1975-N-0336 · posted Apr 25, 2022
Key facts
| Document ID | FDA-1975-N-0336-0121 |
|---|---|
| Title | Drugs for Human Use; Drug Efficacy Study Implementation; Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination With a Sedative, and Single-Entity Antispasmodic Drug Products, in Oral Dosage Form; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation |
| Document type | Notice |
| Subtype | Announcement |
| Agency | FDA |
| Docket | FDA-1975-N-0336 |
| Posted | Apr 25, 2022 |
| Federal Register citation | 87 FR 24311 |
| FR document number | 2022-08740 |
| Comment period opens | Apr 25, 2022 |
| Effective date | Apr 25, 2022 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: